Human IL-6 Antibody

Mouse IgG1 (clone 3H3) - Hybridoma

ABOUT

Neutralizing monoclonal antibody against human interleukin 6

Anti-hIL-6-IgG (clone 3H3) is a monoclonal antibody (mAb) specific for human interleukin 6 (hIL-6). It is produced in hybridomas and purified by affinity chromatography. This antibody has been selected for its ability to efficiently neutralize the biological activity of hIL-6. IL-6 is a multifunctional cytokine that plays an important role in the regulation of the immune response, hematopoiesis, and inflammation [1, 2].

More details More details

 

Key features:

  • A potent and specific neutralizing mAb against hIL-6
  • Provided azide-free
  • No cross-reactivity with murine IL-6
  • Each lot is functionally tested

 

References:

1. Kang S. et al., 2015. Therapeutic uses of anti-interleukin-6 receptor antibody. Int. Immunol. 27: 21-9.
2. Akira S. et al., 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4(11):2860-7.

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Target

IL-6

Target species

Human

Applications

Neutralization assay

Species
Human
Isotype
mIgG1
kappa
Clone
3H3
Tag
Tag-free
Source
Hybridoma
Purification
Protein G
Formulation buffer

Sodium phosphate buffer, glycine, saccharose, stabilizing agents

Preservative
Azide-free
Reconstitution buffer
Sterile water (not provided)
Tested applications

Neutralization assay

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    Anti-hIL-6-IgG
  • Cat code: 
    mabg-hil6-3
  • Quantity: 
    3 x 100 µg

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: -20°C for up to 1 year

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

The proinflammatory cytokine interleukin 6 (IL-6) is one of the most important mediators of fever and of the acute phase response [1, 2]. IL-6 exerts its action by first binding to the IL-6 receptor (IL-6R). The complex of IL-6 and IL-6R associates with the signal-transducing membrane protein gp130, thereby inducing its dimerization.
This leads to the activation by phosphorylation of the tyrosine kinases of the Janus family (JAK1, JAK2, and Tyk2). Activated JAKs induce dimerization and translocation to the nucleus of STAT3 where it binds enhancer elements of IL-6-inducible genes [3].
In HEK-Blue™ IL-6 cells activation of the JAK/STAT3 pathway with IL-6 leads to the production of the secreted alkaline phosphatase (SEAP) reporter.

 

1. Kang S. et al., 2015. Therapeutic uses of anti-interleukin-6 receptor antibody. Int. Immunol. 27: 21-9.
2. Akira S. et al., 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4(11):2860-7.
3. Murray P., 2007. The JAK-STAT Signaling Pathway: Input and Output Integration. J. Immunol. 178:2623-9.

DOCUMENTS

Documents

Anti-hIL-6-IgG

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?